Compare ACRS & SPIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACRS | SPIR |
|---|---|---|
| Founded | 2012 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 311.0M | 292.9M |
| IPO Year | 2015 | 2020 |
| Metric | ACRS | SPIR |
|---|---|---|
| Price | $3.06 | $9.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $9.75 | ★ $13.10 |
| AVG Volume (30 Days) | ★ 1.2M | 432.2K |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 69.01 | N/A |
| EPS | N/A | ★ 2.31 |
| Revenue | $1,683,000.00 | ★ $110,451,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.07 |
| P/E Ratio | ★ N/A | $4.22 |
| Revenue Growth | N/A | ★ 13.15 |
| 52 Week Low | $1.05 | $6.60 |
| 52 Week High | $4.89 | $14.53 |
| Indicator | ACRS | SPIR |
|---|---|---|
| Relative Strength Index (RSI) | 43.84 | 49.44 |
| Support Level | $2.78 | $8.71 |
| Resistance Level | $3.46 | $12.41 |
| Average True Range (ATR) | 0.21 | 0.62 |
| MACD | -0.03 | 0.07 |
| Stochastic Oscillator | 44.53 | 67.55 |
Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.
Spire Global Inc is a provider of space-based data, analytics, and Space Services, offering datasets and powerful insights about Earth from the ultimate vantage point of space so that organizations can make decisions with confidence, accuracy, and speed. It generates revenue from four solutions: Maritime, Aviation, Weather, and Space Services. It offers the following three data solutions to customers; Maritime-precise space-based data used for accurate ship monitoring, ship safety, and route optimization, Aviation-precise space-based data used for accurate aircraft monitoring, aircraft safety, and route optimization, and Weather-precise space-based data used for accurate weather forecasting.